(Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.)
Novelos Therapeutics, Inc. (NVLT) is a development stage pharmaceutical company focused on the development of compounds for the diagnosis and treatment of cancer.
NVLT is developing three candidates, which are nicknamed as LIGHT, HOT and GLOW2, which are cancer-targeted compounds. All three compounds are selectively taken up and retained in cancer cells, including cancer stem cells, versus normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse.
(click to enlarge)(click to enlarge)
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|